ERBB2 and neoplasm: Triple-negative (TN) and HER2-positive (HER2+) subtypes have been consistently reported to show higher levels of tumor infiltrating lymphocytes (TILs) as compared to the HR+/HER2-negative (HER2-) subgroup [2].